文献速递头颈外科

头颈癌治疗后长期阿片类药物使用:系统综述与荟萃分析

Long-Term Opioid Use After Treatment of Head and Neck Cancers: A Systematic Review and Meta-analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2025-11-12

该系统综述与荟萃分析检索2004年7月至2024年7月多个数据库,纳入12项研究共2839例头颈癌患者,计算长期阿片类药物使用的合并率并比较相关因素。结果显示3个月时阿片类药物使用率为44%,6个月时为27%;较高T分期、治疗前阿片类药物使用、酒精使用、烟草使用、心理疾病、慢性疼痛史和胃造瘘管使用在3个月和6个月均与较高使用率相关。

要点

  • 头颈癌患者3个月阿片类药物使用率为44%,6个月为27%。
  • 较高T分期、治疗前阿片使用、酒精/烟草使用、心理疾病、慢性疼痛史和胃造瘘管使用与3个月和6个月较高使用率相关。
  • 喉原发和口咽原发使用率高于口腔原发,化疗或放疗也导致较高使用率。

核心结论

  • 头颈癌患者长期阿片类药物使用率较高,多种人口学、肿瘤学和医学因素与较高使用率相关。

研究设计与样本

  • 系统综述与荟萃分析,检索Cochrane Central、EMBASE、MEDLINE、PsycINFO、CINHAL、PubMed及灰色文献(2004年7月至2024年7月),纳入12项研究共2839例患者。

主要发现

  • 总体阿片类药物使用率3个月为44%,6个月为27%。
  • 3个月和6个月时,较高T分期、治疗前阿片使用、酒精使用、烟草使用、心理疾病、慢性疼痛史和胃造瘘管使用与较高使用率相关。
  • 仅3个月时,淋巴结转移和无加巴喷丁使用与使用相关;仅6个月时,未婚状态与使用相关。
  • 喉原发和口咽原发使用率高于口腔原发,化疗或放疗也导致较高使用率。

临床怎么用

  • 对头颈癌患者应关注长期阿片类药物使用风险,尤其存在较高T分期、治疗前阿片使用、酒精/烟草使用、心理疾病、慢性疼痛史或胃造瘘管使用等特征时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We determined the rates of long-term opioid use in head and neck cancer patients to better understand what characteristics increase the odds of long-term opioid use in these patients. DATA SOURCES: Cochrane Central, EMBASE, MEDLINE, PsycINFO, CINHAL, PubMed, and the gray literature were searched from July 2004 to July 2024. REVIEW METHODS: We included meta-analyses examining the relationship between head and neck cancers and long-term opioid use. We calculated pooled rates and compared factors using confidence intervals, chi square, and odds ratios. RESULTS: Of 90 articles retrieved, 12 were included for meta-analysis for a total of 2839 patients. The overall rates of opioid use were 44% at 3 months and 27% at 6 months. At both 3 and 6 months, higher T stage, pretreatment opioid use, alcohol use, tobacco use, psychological illness, history of chronic pain, and gastrostomy tube use were associated with higher rates of opioid use. Additionally, lymph node metastasis and lack of gabapentin use were also associated with use only at 3 months, whereas unmarried status was only associated with use at 6 months. Overall, laryngeal and oropharyngeal primaries had higher rates of use than oral cavity, and chemotherapy or radiation treatment also led to higher rates of use. CONCLUSION: Head and neck cancer patients have one of the highest rates of long-term opioid use, with various demographic, oncologic, and medical factors associated with higher rates.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Rosen R, Richter J, Cabrera CI, et al. Long-Term Opioid Use After Treatment of Head and Neck Cancers: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2025. PMID: 41221895. doi:10.1002/ohn.70024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。